Empresas y finanzas

KLA?Tencor Announces Results of Tender Offer to Acquire ICOS Vision Systems



    KLA-Tencor Corporation (NASDAQ:KLAC) today announced the results of its

    tender offer to acquire ICOS Vision Systems Corporation NV (Euronext:

    IVIS). KLA-Tencor is the leading supplier of wafer front-end inspection

    and metrology solutions to the global semiconductor industry; ICOS is a

    leading supplier of packaging and interconnect inspection solutions for

    the semiconductor industry, and has a market leadership position in the

    inspection of photovoltaic solar technologies and LED lighting products. The acceptance period for the tender offer ended on Monday, May 19, 2008

    at 4 p.m. (Central European Time). At the close of the initial

    acceptance period for the takeover bid, 10,250,802 shares of ICOS had

    been tendered, constituting 96.03% of the outstanding shares of ICOS.

    The shares tendered into the bid during this initial acceptance period

    are expected to be settled on May 30, 2008. "We are bringing together two long-standing leaders in separate but

    complementary segments of the semiconductor capital-equipment industry

    to extend our leadership as the world´s best process control company,"

    said Rick Wallace, CEO of KLA-Tencor Corporation. "By combining our

    complementary strengths to provide differentiated technical solutions

    we are well positioned to provide even greater value for our customers

    expand our product and service offerings as well as pursue new

    opportunities for growth." As described in the prospectus related to the offer, because KLA-Tencor

    (through its wholly owned subsidiary) will hold more than 95% of the

    shares of ICOS, it will reopen the takeover bid at the same terms in

    order to proceed with a squeeze-out according to article 513, section 1

    of the Company Code and article 42 of the Royal Decree of 27 April 2007

    on takeover bids in order to acquire all the ICOS shares and 2002

    warrants (but not the 2007 options) which as of that time have not been

    tendered to the bid. The bid price is EUR 36.50 for each share and EUR 32.76 for each 2002

    warrant. The acceptance period for the squeeze-out bid is expected to

    begin on May 28, 2008 and to continue until June 17, 2008 at 4 p.m.

    (Central European Time). Further details on the conditions of the

    squeeze-out bid and the subsequent delisting of the ICOS shares are

    given in the formal announcement of the squeeze-out that will appear in

    the Belgian press on May 22, 2008. Additional details regarding the offer and related acceptance procedures

    are set forth in the prospectus related to the offer. The prospectus is

    available in Belgium free of charge at the counters of KBC Securities

    KBC Bank, CBC Banque or by phone +32 3 283 29 70 (KBC telecenter) or

    0800/92020 (CBC Banque) and at Petercam. Electronic versions of the

    prospectus (including the acceptance form) are available on the

    following websites: www.kbcsecurities.be

    www.kbc.be, www.cbcbanque.be

    www.petercam.be and www.kla-tencor.com. About KLA-Tencor: KLA-Tencor is the world leader in yield

    management and process control solutions for semiconductor manufacturing

    and related industries. Headquartered in San Jose, California

    KLA-Tencor has sales and service offices around the world. An S&P 500

    company, KLA-Tencor is traded on the NASDAQ Global Select Market under

    the symbol KLAC. Additional information about KLA-Tencor is available at http://www.kla-tencor.com. About ICOS: ICOS designs and manufactures inspection equipment

    for semiconductor packaging and interconnect applications. It is a

    world-leading supplier of equipment for the visual inspection of IC´s

    before they are used in various applications such as PC´s

    portable phones or cars. ICOS´s systems

    perform two- and three-dimensional (2D and 3D) inspection of IC´s

    wafers, solar cells, substrates, sockets, etc. ICOS offers stand-alone

    inspection systems, as well as inspection modules for integration. ICOS

    is headquartered in Leuven, Belgium and has R&D centers in Belgium

    Germany and Hong Kong, sales and support offices in Japan, the USA

    Singapore, Hong Kong, Korea and Taiwan and production facilities in

    Belgium, Hong Kong and China. Additional information on ICOS is

    available at http://www.icos.be. Disclaimer: With the exception of the CBFA, no other authority in

    any other jurisdiction has approved the prospectus (including any

    supplement thereto). This approval does not entail an assessment of the

    suitability or quality of the bid or any possible squeeze-out. The bid

    is made only in Belgium and the United States, and no steps have been or

    will be taken with a view to obtaining authorization to distribute the

    prospectus in countries other than Belgium and the United States. Forward Looking Statements: Statements in this press release

    other than historical facts, such as statements regarding the potential

    benefits and synergies that may result from the transaction, the

    anticipated settlement date for the shares tendered in the bid and the

    expected timing for the reopening of the bid, are forward-looking

    statements, and are subject to the Safe Harbor provisions created by the

    Private Securities Litigation Reform Act of 1995. These forward-looking

    statements are based on current information and expectations, and

    involve a number of risks and uncertainties. Actual results may differ

    materially from those projected in such statements due to various

    factors, including but not limited to those associated with demand for

    the companies´ respective product lines; the

    results of product development efforts; the success of product offerings

    to meet customer needs within the timeframes required by customers in

    these markets; disruption from the proposed acquisition making it more

    difficult to maintain relationships with customers, vendors and

    employees; the failure to obtain and retain expected synergies from the

    proposed acquisition; unanticipated delays in the transferability of

    funds, the timing of preparation and approval of any documentation

    required in connection with the reopening of the bid or other factors.

    For other factors that may cause actual results to differ materially

    from those projected and anticipated in forward-looking statements in

    this release, please refer to the Company´s

    Annual Report on Form 10-K for the year ended June 30, 2007

    subsequently filed Quarterly Reports on Form 10-Q and other filings with

    the Securities and Exchange Commission (including, but not limited to

    the risk factors described therein).